99 related articles for article (PubMed ID: 3164797)
1. Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
Keating MJ; Smith TL; Kantarjian H; Cork A; Walters R; Trujillo JM; McCredie KB; Gehan EA; Freireich EJ
Leukemia; 1988 Jul; 2(7):403-12. PubMed ID: 3164797
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of residual normal metaphases in acute myelogenous leukemia patients presenting with abnormal karyotype.
Ghaddar HM; Pierce S; Reed P; Estey EH
Leukemia; 1995 May; 9(5):779-82. PubMed ID: 7769840
[TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
[TBL] [Abstract][Full Text] [Related]
4. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases.
Morel P; Hebbar M; Lai JL; Duhamel A; Preudhomme C; Wattel E; Bauters F; Fenaux P
Leukemia; 1993 Sep; 7(9):1315-23. PubMed ID: 8371581
[TBL] [Abstract][Full Text] [Related]
6. Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remission.
Ferrant A; Doyen C; Delannoy A; Straetmans N; Martiat P; Mineur P; Bosly A; Van den Berghe H; Michaux JL
Bone Marrow Transplant; 1995 May; 15(5):685-90. PubMed ID: 7670396
[TBL] [Abstract][Full Text] [Related]
7. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo.
Samuels BL; Larson RA; Le Beau MM; Daly KM; Bitter MA; Vardiman JW; Barker CM; Rowley JD; Golomb HM
Leukemia; 1988 Feb; 2(2):79-83. PubMed ID: 3343866
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
9. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of chromosomal findings in patients with acute myeloid leukemia in a study comparing the efficacy of autologous and allogeneic bone marrow transplantation.
Schouten HC; van Putten WL; Hagemeijer A; Blijham GH; Sonneveld P; Willemze R; Slater R; van de Lely J; Verdonck LF; Löwenberg B
Bone Marrow Transplant; 1991 Nov; 8(5):377-81. PubMed ID: 1768973
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia.
Lo-Coco F; Cuneo A; Pane F; Cilloni D; Diverio D; Mancini M; Testoni N; Bardi A; Izzo B; Bolli N; La Starza R; Fazi P; Iacobelli S; Piciocchi A; Vignetti M; Amadori S; Mandelli F; Pelicci PG; Mecucci C; Falini B; Saglio G;
Haematologica; 2008 Jul; 93(7):1017-24. PubMed ID: 18508799
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of prognostic variables in childhood acute myeloid leukemia].
Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
[TBL] [Abstract][Full Text] [Related]
13. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
[TBL] [Abstract][Full Text] [Related]
14. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.
Brozek I; Babińska M; Kardaś I; Woźniak A; Balcerska A; Hellmann A; Limon J
J Appl Genet; 2003; 44(3):401-12. PubMed ID: 12923315
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.
Kornblau SM; Thall PF; Estrov Z; Walterscheid M; Patel S; Theriault A; Keating MJ; Kantarjian H; Estey E; Andreeff M
Clin Cancer Res; 1999 Jul; 5(7):1758-66. PubMed ID: 10430080
[TBL] [Abstract][Full Text] [Related]
18. Chromosomal abnormalities in myelodysplastic syndromes and acute myeloid leukemia.
Machnicki JL; Bloomfield CD
Clin Lab Med; 1990 Dec; 10(4):755-67. PubMed ID: 2272173
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics for detection of minimal residual disease in acute myeloblastic leukemia.
Freireich EJ; Cork A; Stass SA; McCredie KB; Keating MJ; Estey EH; Kantarjian HM; Trujillo JM
Leukemia; 1992 Jun; 6(6):500-6. PubMed ID: 1602788
[TBL] [Abstract][Full Text] [Related]
20. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia.
Oran B; Dolan M; Cao Q; Brunstein C; Warlick E; Weisdorf D
Biol Blood Marrow Transplant; 2011 Mar; 17(3):356-64. PubMed ID: 20553926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]